Heart Rate Variability Biofeedback for Female Sexual Arousal Disorder
| Status: | Completed |
|---|---|
| Conditions: | Psychiatric |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - 40 |
| Updated: | 10/13/2018 |
| Start Date: | October 2016 |
| End Date: | January 2018 |
Autonomic Imbalance and Female Sexual Arousal Disorder: The Identification of Heart Rate Variability Level as a Risk Factor and Treatment Target
Low resting heart rate variability (HRV) has been associated with sexual arousal problems and
overall sexual dysfunction in women. Research has indicated that HRV biofeedback leads to
increases in HRV as well as improvements in symptoms associated with several psychological
disorders, some of which are comorbid with sexual arousal problems in women. Autogenic
training also facilitates increases in HRV and was recently associated with acute increases
in sexual arousal among sexually healthy women. The primary aim of the current study is to
examine the efficacy of HRV biofeedback, with and without autogenic training, for the
treatment of female sexual arousal disorder (FSAD).
overall sexual dysfunction in women. Research has indicated that HRV biofeedback leads to
increases in HRV as well as improvements in symptoms associated with several psychological
disorders, some of which are comorbid with sexual arousal problems in women. Autogenic
training also facilitates increases in HRV and was recently associated with acute increases
in sexual arousal among sexually healthy women. The primary aim of the current study is to
examine the efficacy of HRV biofeedback, with and without autogenic training, for the
treatment of female sexual arousal disorder (FSAD).
Women who meet ICD-10-CM diagnostic criteria for FSAD will be recruited and randomized into
one of three conditions, HRV biofeedback (n = 25), HRV biofeedback plus autogenic training (n
= 25), or wait-list control (n = 15). All participants will complete a baseline assessment,
during which their resting state HRV and vaginal pulse amplitude (VPA) will be measured. The
participants in the two biofeedback conditions will receive training in HRV biofeedback from
the experimenter, and they will be provided with the materials necessary to guide
self-practice in HRV biofeedback at home. Participants in these two conditions will be
instructed to engage in at-home HRV biofeedback (with or without autogenic training) at least
5 times over a period of two weeks, during which they will report levels of arousal in a
sexual activity diary. Participants in the wait-list control condition will report levels of
arousal in a sexual activity diary. After two weeks, participants in all three conditions
will return to the laboratory, where their physiological and psychological sexual arousal
will be measured. Over the next two weeks, participants in the two biofeedback conditions
will be asked to complete 5 more self-guided biofeedback sessions along with the sexual
activity diary. Participants in all three conditions will return to the lab for a final
assessment to measure post-treatment HRV and VPA levels as well as psychological sexual
arousal. To our knowledge, this study will be the first randomized controlled trial of HRV
biofeedback in women with sexual arousal problems. If the intervention increases arousal in
this population, this study may offer a promising cost-effective psychosocial treatment for
women with sexual arousal problems.
one of three conditions, HRV biofeedback (n = 25), HRV biofeedback plus autogenic training (n
= 25), or wait-list control (n = 15). All participants will complete a baseline assessment,
during which their resting state HRV and vaginal pulse amplitude (VPA) will be measured. The
participants in the two biofeedback conditions will receive training in HRV biofeedback from
the experimenter, and they will be provided with the materials necessary to guide
self-practice in HRV biofeedback at home. Participants in these two conditions will be
instructed to engage in at-home HRV biofeedback (with or without autogenic training) at least
5 times over a period of two weeks, during which they will report levels of arousal in a
sexual activity diary. Participants in the wait-list control condition will report levels of
arousal in a sexual activity diary. After two weeks, participants in all three conditions
will return to the laboratory, where their physiological and psychological sexual arousal
will be measured. Over the next two weeks, participants in the two biofeedback conditions
will be asked to complete 5 more self-guided biofeedback sessions along with the sexual
activity diary. Participants in all three conditions will return to the lab for a final
assessment to measure post-treatment HRV and VPA levels as well as psychological sexual
arousal. To our knowledge, this study will be the first randomized controlled trial of HRV
biofeedback in women with sexual arousal problems. If the intervention increases arousal in
this population, this study may offer a promising cost-effective psychosocial treatment for
women with sexual arousal problems.
Inclusion Criteria:
- Premenopausal (18-40 years)
- Fluent in English
- Heterosexual or bisexual
- Score of 26.55 or less on the Female Sexual Function Index (FSFI)
- Current sexual arousal dysfunction
- Ownership of an Elite HRV compatible device (recent iPhone, iPad, or Android)
Exclusion Criteria:
- Pregnant or breastfeeding
- History of or current sexually transmitted infections
- History of major pelvic surgery
- History of childhood sexual abuse
- Currently taking androgens, estrogens, or other medical treatments to enhance sexual
arousal
- Current psychosis
- If on antidepressants or antihypertensives, must be stabilized for at least 3 months
We found this trial at
1
site
Click here to add this to my saved trials
